imatinib mesylate has been researched along with Facial Dermatoses in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abreu, MH; Gomez, RS; Resende, RG; Silva, ME; Teixeira, RG; Vasconcelos, Fde O | 1 |
| Carrasco-Daza, D; de Ocariz, MS; Durán-McKinster, C; García-Romero, MT; Orozco-Covarrubias, L; Palacios-López, C; Ruiz-Maldonado, R | 1 |
| Sawamura, D; Shimizu, H; Yanagi, T | 1 |
3 other study(ies) available for imatinib mesylate and Facial Dermatoses
| Article | Year |
|---|---|
Imatinib-associated hyperpigmentation of the palate in post-HSCT patient.
Topics: Adult; Antineoplastic Agents; Benzamides; Ear Diseases; Ear, External; Facial Dermatoses; Hematopoietic Stem Cell Transplantation; Humans; Hyperpigmentation; Imatinib Mesylate; Male; Maxillary Diseases; Neoplasms, Second Primary; Neurofibromatosis 1; Nose Diseases; Palate, Hard; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Pyrimidines; Tissue Conditioning, Dental | 2012 |
Imatinib mesylate-induced neutrophilic folliculitis in a teenager.
Topics: Adolescent; Antineoplastic Agents; Benzamides; Facial Dermatoses; Female; Folliculitis; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neutrophils; Piperazines; Pyrimidines | 2012 |
Follicular mucinosis associated with imatinib (STI571).
Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Facial Dermatoses; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Mucinosis, Follicular; Piperazines; Pyrimidines | 2004 |